These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Antithrombotic effects of BMY21190, an inhibitor of cAMP phosphodiesterase, in a canine model of coronary artery thrombosis. Minami M; Driscoll EM; Lucchesi BR Jpn Circ J; 1993 Oct; 57(10):979-92. PubMed ID: 8230679 [TBL] [Abstract][Full Text] [Related]
28. Aurintricarboxylic acid in a canine model of coronary artery thrombosis. Strony J; Phillips M; Brands D; Moake J; Adelman B Circulation; 1990 Mar; 81(3):1106-14. PubMed ID: 2306818 [TBL] [Abstract][Full Text] [Related]
29. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. Gurbel PA; Anderson RD; MacCord CS; Scott H; Komjathy SF; Poulton J; Stafford JL; Godard J Circulation; 1994 Jan; 89(1):361-5. PubMed ID: 8281671 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults. Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor. Torr SR; Haskel EJ; VonVoigtlander PF; Bergmann SR; Abendschein DR J Am Coll Cardiol; 1991 Dec; 18(7):1804-10. PubMed ID: 1960333 [TBL] [Abstract][Full Text] [Related]
33. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model. Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285 [TBL] [Abstract][Full Text] [Related]
34. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Yasuda T; Gold HK; Leinbach RC; Yaoita H; Fallon JT; Guerrero L; Napier MA; Bunting S; Collen D Circulation; 1991 Mar; 83(3):1038-47. PubMed ID: 1900221 [TBL] [Abstract][Full Text] [Related]